Advanced Diabetes Supply (ADS), a national provider who distributes specialized diabetes devices under its ADS and US MED brands, has announced that it’s now providing Abbott’s new FreeStyle Libre 2 Plus continuous glucose monitoring (CGM) sensor.
The Jan. 30 news announcement said ADS, based in Carlsbad, Calif., and US MED are “the first durable medical equipment providers in the country to offer consumers the 15-day sensor — the longest-lasting non-implantable sensor on the market, and the first Libre sensor to integrate with an insulin pump.”
Abbott’s FreeStyle Libre 2 Plus sensor integrates with the Tandem t:slim X2 insulin pump with Control-IQ technology. It’s been approved for patients as young as 2 and is able to provide improved accuracy, particularly in the low-glucose range, the manufacturer reported.
The FreeStyle Libre 2 Plus currently works only with the FreeStyle Libre 2 CGM reader and FreeStyle Libre 2 app, though the announcement said the FreeStyle Libre 2 “is expected to integrate with other automated insulin delivery devices, such as the Omnipod Dash, in the future.”
Bill Mixon, CEO of ADS, said in the announcement, “The FreeStyle Libre 2 Plus is an exciting advancement in diabetes health technology and is the only 15-day non-implantable continuous glucose monitoring (CGM) sensor in the U.S. As leading distributors of FreeStyle Libre, we are pleased to be the first to add this valuable tool to our product offerings as we continue to seek new and innovative ways to support the diabetic community.”
Mixon added, “We’re proud to be able to partner with companies like Abbott who are working to provide advanced tools and technologies to empower individuals with diabetes in managing their health. We are grateful to have played a small role in bringing this sensor to the market and excited to see the difference this product will make in the daily lives of those we serve.”
